Drug Transporter (DT) Information
General Information and Variability Data of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0020 | ||||
Gene Name | SLC10A2 | ||||
Protein Name | Apical sodium-dependent bile acid transporter | ||||
Synonyms | ASBT; IBAT; ISBT; Ileal Na(+)/bile acid cotransporter; Ileal sodium-dependent bile acid transporter; Ileal sodium/bile acid cotransporter; NTCP2; Na(+)-dependent ileal bile acid transporter; PBAM; SLC10A2; Sodium/taurocholate cotransporting polypeptide, ileal; Solute carrier family 10 member 2 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
DT Family | Bile Acid:Na(+) Symporter (BASS) Family ; | ||||
Function | This transporter plays a critical role in the sodium-dependent reabsorption of bile acids from the lumen of the small intestine. | ||||
Genetic Polymorphisms & Epigenetic Regulations of DT | |||||
Species-, Tissue- and Disease-specific Protein Abundances of DT | |||||
Exogenous Factor Altering DT Activity | |||||
Approved Drug(s) Transported by This DT | Cholic acid | Drug Info | Synthesis disorders [ICD-11: 5C52.10] | Approved | [1] |
Deoxycholic acid | Drug Info | Fat below the chin [ICD-11: 5B80] | Approved | [2] | |
Withdrawn, Discontinued or Preclinical Drug(s) Transported by This DT | Glycodeoxycholic acid | Drug Info | Asthma [ICD-11: CA23] | Preclinical | [1] |
Sodium taurocholate | Drug Info | Type 2 diabetes [ICD-11: 5A11] | Preclinical | [3] | |
Taurocholic acid | Drug Info | Type 2 diabetes [ICD-11: 5A11] | Terminated | [3] | |
Endogenous Substrate(s) | Bile acids; Bile conjugates; Cholate; Glycochenodeoxycholate | ||||
Endogenous Metabolites (EMs) Handled by This DT | Bile acid unspecific | EM Info | Identified using actively drinking cirrhotic patients | [4] | |
Drug-DT Affinity Assessed by Cell Line | |||||
Drug(s) with Drug-DT Affinity Data | Sodium taurocholate | Drug Info | Human embryonic kidney cells (HEK293)-ASBT | Km = 9.4 microM | [3] |
Sodium taurocholate | Drug Info | Monkey kidney fibroblast-like cell (COS)1-ASBT | Km = 13.3 microM | [5] | |
Sodium taurocholate | Drug Info | Monkey kidney fibroblast-like cell (COS)7-ASBT | Km = 16 microM | [6] | |
Taurocholic acid | Drug Info | Human embryonic kidney cells (HEK293)-ASBT | Km = 9.4 microM | [3] | |
Taurocholic acid | Drug Info | Monkey kidney fibroblast-like cell (COS)1-ASBT | Km = 13.3 microM | [5] | |
References | |||||
1 | Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998 Jan;274(1):G157-69. | ||||
2 | Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. Biomaterials. 2018 Jan;151:13-23. | ||||
3 | Identification of a region of the ileal-type sodium/bile acid cotransporter interacting with a competitive bile acid transport inhibitor. Biochemistry. 2002 Dec 17;41(50):14916-24. | ||||
4 | Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut-Liver Axis. Alcohol Clin Exp Res. 2017 Nov;41(11):1857-1865. | ||||
5 | Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998 Jan;274(1 Pt 1):G157-69. | ||||
6 | Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2039-45. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.